Business Wire

Siemens and Bentley Systems Collaborate on Process Industries Academy Initiative

Del

(from ACHEMA, World Forum for the Process Industries) − Siemens’ Process Industries and Drives and Digital Factories divisions are teaming up with Bentley Systems’ Bentley Institute to establish a Process Industries Academy that will support the companies’ joint vision for cloud services and digital workflows in engineering and operations. The Process Industries Academy will help organizations to better understand and develop an effective digital strategy across all aspects of the asset lifecycle, based on the practical experience and knowledge of the industry’s leading experts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612006205/en/

The Process Industries Academy helps organizations develop digital strategy best practices based on  ...

The Process Industries Academy helps organizations develop digital strategy best practices based on practical knowledge from industry experts. (Photo: Bentley Systems)

With recent fluctuations in the oil, gas, and global energy markets, and the subsequent impact on related process manufacturing sectors, established ways of working in the process industries are now being challenged across the entire project lifecycle. Fewer capital investments in greenfield projects, and an increased focus on optimizing productivity, performance and utilization of existing assets, have prompted the process industries to examine new ways to increase competitiveness and operating revenues.

An optimal approach to project delivery and asset performance addresses the interactions and balance between an organization’s capabilities, its people, the underlying business processes and methods, all coupled with the latest technology, to consistently improve its business outcomes.

Based on the experience and knowledge of the industry’s leading experts, the Process Industries Academy will provide sessions focusing on real-world examples of the key aspects of a digital approach to capital project delivery and asset operations. Participants will discover how developing a clear digital strategy for improved collaboration, communication, and coordination between project teams creates an ideal environment to optimize information creation and digital workflows.

Eckard Eberle, CEO, Process Automation, Process Industries and Drives Division, Siemens AG, said, “The Process Industries Academy supports the development of industry best-practice approaches, while respecting the culture and traditions within today’s process industries. Our shared vision for the academy is to offer a practical, effective means for asset owners, decision makers, and program and project managers to understand the interactions and balance between teams, processes, and technologies so they can see improved project delivery and asset performance.”

Alan Lamont, vice president of Digital Advancement Academies for Bentley Systems, said, “The Process Industries Academy will offer industry professionals an environment to learn and share practical insights about business process improvements enabled by technology, so they can educate and equip their teams to be more productive and achieve the best outcomes. With academy sessions, we hope to help participants to develop a better understanding of their role and the benefits across the asset lifecycle, with practical, real-world examples of “Going Digital” to advance capital project delivery and asset operations.”

Process Industries Academies will be situated in the following locations to support the global process industry:

  • Karlsruhe, Germany at Siemens’ Process Automation World
  • Houston, Texas, U.S. in Bentley’s Digital Advancement Academy
  • Shanghai, China at Siemens’ Process Industry Center of Excellence

The first academy session is scheduled for November 14, 2018 in Karlsruhe at Siemens Process Automation World. A half-day preview of the Process Industries Academy will be featured during Bentley’s Year in Infrastructure 2018 Conference in London on Monday, October 15.

Caption and image link: The Process Industries Academy will help organizations develop a digital strategy based on practical experience and knowledge from leading experts.
Attribution: Photo courtesy of Bentley Systems

Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. www.siemens.com

Bentley Institute advances the infrastructure professions by encouraging and supporting going digital. Its initiatives advance and attract current and future infrastructure professionals through continuous learning about technology solutions, as well as project delivery and asset performance best practices. Bentley Institute’s Digital Advancement Academies facilitate an environment and a culture of innovation via awareness sessions, forums, and targeted seminars and working groups, helping to ensure that all project collaborators fully understand the digital processes, standards, and deliverables expected for successful project outcomes. www.bentley.com/learn

Bentley Systems, Incorporated is a global leader dedicated to providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing infrastructure. Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, and is on track to surpass an annual revenue run rate of $700 million. Since 2012, Bentley has invested more than $1 billion in research, development, and acquisitions. www.bentley.com

Bentley and the Bentley logo are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

Contact information

Bentley Systems, Incorporated
Press Contact:
Jennifer Maguire
+1 610-458-2695
jennifer.maguire@bentley.com
Follow us on Twitter:
@BentleySystems
or
Siemens AG
Evelyne Kadel
evelyne.kadel@siemens.com
+49 211 69161003

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i